1-7 of 7
Joshua D. Brandstadter
Close
Sort by
Journal Articles

Clinical Characteristics and Treatment Outcomes of Idiopathic Multicentric Castleman Disease: Data from a Pediatric Cohort

Saishravan Shyamsundar, Mateo Sarmiento Bustamante, Sheila K. Pierson, Joshua D. Brandstadter, Frits van Rhee, David C. Fajgenbaum
Journal: Blood
Blood (2023) 142 (Supplement 1): 4415.
https://doi.org/10.1182/blood-2023-183039
Published: 2023
Journal Articles

Clinical Characteristics, Treatment Trends, and Outcomes of Patients with HHV-8-Negative/Idiopathic Multicentric Castleman Disease Treated with Siltuximab in a Machine Learning-Selected Real-World Cohort

Aaron B Cohen, Melissa Estevez, Jonathan G Kelly, James N Gippetti, Erin L Fidyk, Joshua D. Brandstadter, David C. Fajgenbaum
Journal: Blood
Blood (2023) 142 (Supplement 1): 907.
https://doi.org/10.1182/blood-2023-174924
Published: 2023
Journal Articles

Fibroblastic Stromal Cells Expressing Delta-like Notch Ligands Control Extrathymic T Cell Development in Mesenteric Lymph Nodes

Ashley Vanderbeck, Samantha Kelly, Leolene Carrington, Eric Perkey, Anneka Allman, Frederick Allen, Joshua D Brandstadter, Burkhard Ludewig, Chris Siebel
Journal: Blood
Blood (2022) 140 (Supplement 1): 7363.
https://doi.org/10.1182/blood-2022-169178
Published: 2022
Journal Articles

Increased Comorbidities and Hospitalizations Associated with Idiopathic Multicentric Castleman Disease

Mateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, Daisy Alapat, Adam Bagg, Joshua D Brandstadter, Mary Jo Lechowicz, Hongzhe Lee, Gordan Srkalovic, Megan S. Lim, Frits van Rhee, David C Fajgenbaum
Journal: Blood
Blood (2022) 140 (Supplement 1): 6520–6521.
https://doi.org/10.1182/blood-2022-170102
Published: 2022
Journal Articles

Longitudinal, Real-World Data Reveal Treatment Effectiveness in Idiopathic Multicentric Castleman Disease and Support Current Treatment Guidelines

Sheila K Pierson, Mateo Sarmiento Bustamante, Joshua D Brandstadter, Daisy Alapat, Adam Bagg, Mary Jo Lechowicz, Gordan Srkalovic, Megan S. Lim, Frits van Rhee, David C Fajgenbaum
Journal: Blood
Blood (2022) 140 (Supplement 1): 9378–9379.
https://doi.org/10.1182/blood-2022-170360
Published: 2022
Journal Articles

A Novel Cryopreservation and Biobanking Strategy to Study Lymphoid Tissue Stromal Cells in Lymphoproliferative Disorders

Joshua D Brandstadter, Angelina De Martin, Mechthild Lϋetge, Antonio Ferreira, Brian T. Gaudette, Michael Gonzalez, Yves Stanossek, Edward Camiolo, Gerald Wertheim, David Allman, David C Fajgenbaum, Jon C. Aster, Burkhard Ludewig, Ivan Maillard
Journal: Blood
Blood (2022) 140 (Supplement 1): 3562–3563.
https://doi.org/10.1182/blood-2022-159835
Published: 2022
Journal Articles

Dll1 and Dll4 Notch Ligands Prime T Cell Alloimmunity and Are Expressed in Non-Overlapping Populations of Fibroblastic Stromal Cells in Spleen and Lymph Nodes at the Onset of Gvhd

Joshua D Brandstadter, MD PhD, Eric Perkey, Brian T. Gaudette, PhD, Léolène Carrington, PhD, Daniela Gomez-Atria, PhD, Bruce R. Blazar, MD, Burkhard Ludewig, PhD, Anastasia Tikhonova, PhD, Iannis Aifantis, PhD, David Allman, PhD, Ivan Maillard, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 588.
https://doi.org/10.1182/blood-2019-123533
Published: 2019